INR 21.88
(-3.48%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 932.7 Million INR | -33.54% |
2022 | 3.69 Billion INR | 86.9% |
2021 | 1.97 Billion INR | 1.16% |
2020 | 1.95 Billion INR | -6.69% |
2019 | 2.09 Billion INR | -0.63% |
2018 | 2.1 Billion INR | 9.3% |
2017 | 1.92 Billion INR | -3.25% |
2016 | 1.99 Billion INR | -1.15% |
2015 | 2.01 Billion INR | 3.01% |
2014 | 1.95 Billion INR | 8.61% |
2013 | 1.8 Billion INR | 3.14% |
2012 | 1.74 Billion INR | 26.16% |
2011 | 1.38 Billion INR | 28.53% |
2010 | 1.07 Billion INR | -84.85% |
2009 | 7.11 Billion INR | 4.89% |
2008 | 6.78 Billion INR | 6.99% |
2007 | 6.34 Billion INR | 55.57% |
2006 | 4.07 Billion INR | 79.18% |
2005 | 2.27 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 581.67 Million INR | -4.65% |
2023 Q1 | 947.41 Million INR | 0.72% |
2023 FY | 2.45 Billion INR | -33.54% |
2023 Q4 | 610.04 Million INR | 0.02% |
2023 Q3 | 609.94 Million INR | -38.15% |
2023 Q2 | 986.17 Million INR | 4.09% |
2022 Q3 | 870.5 Million INR | -14.81% |
2022 Q1 | 862.94 Million INR | 258.02% |
2022 FY | 3.69 Billion INR | 86.9% |
2022 Q2 | 1.02 Billion INR | 18.41% |
2022 Q4 | 940.67 Million INR | 8.06% |
2021 FY | 1.97 Billion INR | 1.16% |
2021 Q4 | -546.08 Million INR | -163.77% |
2021 Q3 | 856.37 Million INR | -1.74% |
2021 Q2 | 871.55 Million INR | 9.57% |
2021 Q1 | 795.43 Million INR | 263.92% |
2020 FY | 1.95 Billion INR | -6.69% |
2020 Q2 | 808.52 Million INR | -1.13% |
2020 Q1 | 817.77 Million INR | 259.04% |
2020 Q4 | -485.26 Million INR | -159.64% |
2020 Q3 | 813.6 Million INR | 0.63% |
2019 Q3 | 850.98 Million INR | -4.54% |
2019 Q4 | -514.21 Million INR | -160.42% |
2019 Q2 | 891.5 Million INR | 2.87% |
2019 FY | 2.09 Billion INR | -0.63% |
2019 Q1 | 866.59 Million INR | 247.63% |
2018 Q2 | 887.52 Million INR | 4.98% |
2018 Q1 | 845.4 Million INR | 0.0% |
2018 FY | 2.1 Billion INR | 9.3% |
2018 Q4 | -587 Million INR | -161.0% |
2018 Q3 | 962.33 Million INR | 8.43% |
2017 FY | 1.92 Billion INR | -3.25% |
2016 FY | 1.99 Billion INR | -1.15% |
2015 Q3 | - INR | 0.0% |
2015 FY | 2.01 Billion INR | 3.01% |
2015 Q4 | - INR | 0.0% |
2014 FY | 1.95 Billion INR | 8.61% |
2014 Q4 | - INR | 0.0% |
2014 Q3 | - INR | 0.0% |
2013 FY | 1.8 Billion INR | 3.14% |
2012 FY | 1.74 Billion INR | 26.16% |
2011 FY | 1.38 Billion INR | 28.53% |
2010 FY | 1.07 Billion INR | -84.85% |
2009 FY | 7.11 Billion INR | 4.89% |
2008 FY | 6.78 Billion INR | 6.99% |
2007 FY | 6.34 Billion INR | 55.57% |
2006 FY | 4.07 Billion INR | 79.18% |
2005 FY | 2.27 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.123% |
Hester Biosciences Limited | 908.84 Million INR | -2.625% |
Aarti Drugs Limited | 1.16 Billion INR | 20.11% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 69.662% |
Albert David Limited | 1.02 Billion INR | 9.107% |
Alembic Limited | 872.45 Million INR | -6.905% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.159% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -104.726% |
Bajaj HealthCare Limited | 985.34 Million INR | 5.343% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -13575.953% |
Brooks Laboratories Limited | 51.18 Million INR | -1722.392% |
Eris Lifesciences Limited | 4.94 Billion INR | 81.131% |
FDC Limited | 3.49 Billion INR | 73.35% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.988% |
Gufic Biosciences Limited | 1.18 Billion INR | 21.397% |
Hikal Limited | 4.46 Billion INR | 79.105% |
Ind-Swift Limited | 946.56 Million INR | 1.465% |
Innova Captab Limited | 931.03 Million INR | -0.179% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 57.624% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -112.678% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.547% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 13.171% |
Lupin Limited | 125.09 Billion INR | 99.254% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -474.932% |
Medico Remedies Limited | 59.67 Million INR | -1462.966% |
Morepen Laboratories Limited | 1.98 Billion INR | 53.071% |
Orchid Pharma Limited | 800.77 Million INR | -16.475% |
Procter & Gamble Health Limited | 2.99 Billion INR | 68.862% |
RPG Life Sciences Limited | 1.63 Billion INR | 42.972% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -126.149% |
Sigachi Industries Limited | 579.88 Million INR | -60.842% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 63.482% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 33.511% |
Themis Medicare Limited | 1.12 Billion INR | 17.152% |
Unichem Laboratories Limited | 6.72 Billion INR | 86.133% |
Vaishali Pharma Limited | 84.02 Million INR | -1009.974% |
Wanbury Limited | 978.96 Million INR | 4.726% |
Windlas Biotech Limited | 1 Billion INR | 7.333% |
ZIM Laboratories Limited | 1.01 Billion INR | 7.932% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 56.091% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.088% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.395% |
Venus Remedies Limited | 1.91 Billion INR | 51.328% |
Sakar Healthcare Limited | 204.07 Million INR | -357.029% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.324% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.418% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 62.292% |
Mankind Pharma Limited | 29.27 Billion INR | 96.814% |
Sequent Scientific Limited | 2.9 Billion INR | 67.858% |
Laurus Labs Limited | 11.9 Billion INR | 92.169% |
Neuland Laboratories Limited | 2.92 Billion INR | 68.164% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.695% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.014% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.255% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 55.459% |
Wockhardt Limited | 8.48 Billion INR | 89.001% |
Bal Pharma Limited | 555.62 Million INR | -67.865% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.027% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 34.281% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1500.157% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 57.107% |
Shilpa Medicare Limited | 3.33 Billion INR | 72.026% |
Valiant Laboratories Limited | 138.02 Million INR | -575.728% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.938% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6462.302% |
Granules India Limited | 10.31 Billion INR | 90.956% |
Medicamen Biotech Limited | 335.16 Million INR | -178.279% |
Syncom Formulations (India) Limited | 345.63 Million INR | -169.853% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.535% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.646% |
NATCO Pharma Limited | 10.05 Billion INR | 90.727% |
Suven Life Sciences Limited | 109.75 Million INR | -749.841% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1920.756% |
Strides Pharma Science Limited | 9.16 Billion INR | 89.82% |
Indoco Remedies Limited | 12.06 Billion INR | 92.267% |
Alpa Laboratories Limited | 127.38 Million INR | -632.219% |
Lasa Supergenerics Limited | 291.17 Million INR | -220.324% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 69.686% |